Reuters exclusively reports G20 snubs COVID patent waiver, waters down pledge on WHO’s funding - Reuters News Agency
Health

Reuters exclusively reports G20 snubs COVID patent waiver, waters down pledge on WHO’s funding

Reuters reported exclusively that leaders of the world’s largest economies back “voluntary licensing” of COVID-19 vaccine patents, the drafted conclusions of the Global Health Summit show, watering down a U.S. push for waivers and earlier commitments to supply more funds to the World Health Organization. The draft document, seen by Reuters, is the result of a compromise among experts from G20 nations which remain divided over the waiving of intellectual property rights for COVID-19 vaccines.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Global
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Subscribe
Sign up for email updates